CBP reminds pharmaceutical trade community of their legal obligations in light of ‘most-favored-nation' drug-pricing requirements

WASHINGTON – U.S. Customs and Border Protection reminds the trade community that under the Trump Administration's Executive Order, “Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients,” the U.S. Department of Health and Human Services has published price targets for prescription drugs to lower health care costs for Americans.

Declaring incorrect value on import or export documentation submitted to CBP is considered trade evasion, and CBP will pursue any violations to the fullest extent possible. Such violations may be reported to CBP through the e-Allegations Online Trade Violation Reporting System.

For the latest CBP Office of Trade updates and guidance, follow us on X @CBPTradeGov and on LinkedIn at  https://www.linkedin.com/showcase/cbp-office-of-trade.

-CBP-

U.S. Customs and Border Protection (CBP) is America's frontline: the nation's largest law enforcement organization and the world's first unified border management agency. The 65,000+ men and women of CBP protect America on the ground, in the air, and on the seas. We facilitate safe, lawful travel and trade and ensure our country's economic prosperity. We enhance the nation's security through innovation, intelligence, collaboration, and trust.